These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 515498)

  • 21. Pharmacokinetic analysis of intravenously and orally administered quinidine in cows.
    McGuirk SM; Muir WW; Sams RA
    Am J Vet Res; 1981 Sep; 42(9):1482-7. PubMed ID: 7325456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of hydralazine in human whole blood.
    Ludden TM; Ludden LK; Wade KE; Allerheiligen SR
    J Pharm Sci; 1983 Jun; 72(6):693-5. PubMed ID: 6875831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the stability of aromatic hydrazones in plasma and related biological material.
    Kovaríková P; Mrkvicková Z; Klimes J
    J Pharm Biomed Anal; 2008 Jun; 47(2):360-70. PubMed ID: 18294799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between oral hydralazine and propranolol. I. Changes in absorption, presystemic clearance and splanchnic blood flow.
    Heinzow B; Corbett H; Constantinides S; Bourne R; McLean AJ
    J Pharmacol Exp Ther; 1984 May; 229(2):509-14. PubMed ID: 6716273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of azapropazone following single oral and intravenous doses.
    Breuing KH; Gilfrich HJ; Meinertz T; Jähnchen E
    Arzneimittelforschung; 1979; 29(6):971-2. PubMed ID: 582795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism of hydralazine in man. Part II: Investigation of features relevant to drug safety.
    Dubois JP; Schmid K; Riess W; Hanson A; Henningsen NC; Andersson OK
    Arzneimittelforschung; 1987 Feb; 37(2):189-93. PubMed ID: 3580022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of hydralazine and a major metabolite, pyruvate hydrazone, to rat plasma protein and human serum albumin.
    Ogiso T; Iwaki M
    Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):3155-63. PubMed ID: 6518593
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma concentration and acetylator phenotype determine response to oral hydralazine.
    Shepherd AM; McNay JL; Ludden TM; Lin MS; Musgrave GE
    Hypertension; 1981; 3(5):580-5. PubMed ID: 7298112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration.
    Täuber U; Haack D; Nieuweboer B; Kloss G; Vecsei P; Wendt H
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):48-55. PubMed ID: 6698661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxicokinetics of deltamethrin and its 4'-HO-metabolite in the rat.
    Anadón A; Martinez-Larrañaga MR; Fernandez-Cruz ML; Diaz MJ; Fernandez MC; Martinez MA
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):8-16. PubMed ID: 8917670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies in the rabbit on 3-methyltriazolophthalazine, an acetylated metabolite of hydralazine. Evidence for an alternative route of formation.
    Talseth T; Haegele KD; McNay JL
    Drug Metab Dispos; 1980; 8(2):73-6. PubMed ID: 6103791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of tramadol in horses after intravenous, intramuscular and oral administration.
    Shilo Y; Britzi M; Eytan B; Lifschitz T; Soback S; Steinman A
    J Vet Pharmacol Ther; 2008 Feb; 31(1):60-5. PubMed ID: 18177320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma levels of real and "apparent" hydralazine in man and rat.
    Zak SB; Lukas G; Gilleran TG
    Drug Metab Dispos; 1977; 5(2):116-21. PubMed ID: 15803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioavailability, metabolism, and renal excretion of benzoic acid in the channel catfish (Ictalurus punctatus).
    Plakas SM; James MO
    Drug Metab Dispos; 1990; 18(5):552-6. PubMed ID: 1981701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacokinetics and pharmacodynamics of alfaxalone in cats after single and multiple intravenous administration of Alfaxan at clinical and supraclinical doses.
    Whittem T; Pasloske KS; Heit MC; Ranasinghe MG
    J Vet Pharmacol Ther; 2008 Dec; 31(6):571-9. PubMed ID: 19000281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of hydralazine, an antihypertensive and DNA-demethylating agent, using controlled-release formulations designed for use in dosing schedules based on the acetylator phenotype.
    Gonzalez-Fierro A; Vasquez-Bahena D; Taja-Chayeb L; Vidal S; Trejo-Becerril C; Pérez-Cardenas E; de la Cruz-Hernández E; Chávez-Blanco A; Gutiérrez O; Rodriguez D; Fernandez Z; Duenas-González A
    Int J Clin Pharmacol Ther; 2011 Aug; 49(8):519-24. PubMed ID: 21781652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability of plasma hydralazine concentrations in male hypertensive patients.
    Ludden TM; McNay JL; Shepherd AM; Lin MS
    Arthritis Rheum; 1981 Aug; 24(8):987-93. PubMed ID: 7284051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability problems with hydralazine p-anisaldehyde hydrazone.
    Semple HA; Tam YK; Croteau SM; Coutts RT
    J Pharm Sci; 1989 May; 78(5):432-4. PubMed ID: 2501474
    [No Abstract]   [Full Text] [Related]  

  • 39. Liquid chromatographic determination of dihydralazine and hydralazine in human plasma and its application to pharmacokinetic studies of dihydralazine.
    Rouan MC; Campestrini J
    J Pharm Sci; 1985 Dec; 74(12):1270-3. PubMed ID: 4087193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma levels of free and acid-labile hydralazine: effects of multiple dosing and of procainamide.
    Schneck DW; Sprouse JS; Miller K; Vary JE; DeWitt FO; Hayes AH
    Clin Pharmacol Ther; 1978 Dec; 24(6):714-9. PubMed ID: 710029
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.